Loading...
 
Mediterr J Rheumatol 2023;34(3):284-91
Overview of Rheumatoid Arthritis and Scientific Understanding of the Disease
Authors Information

1Department of Biochemistry, University College of Medical Sciences and GTB Hospital (University of Delhi), Dilshad Garden, Delhi, India

2Department of Orthopaedics, University College of Medical Sciences and GTB Hospital (University of Delhi), Dilshad Garden, Delhi, India

3Department of Orthopaedics, All India Institute of Medical Sciences (AIIMS) Bhopal, India

References
  1. Hashemi M, Atabaki M, Daneshvar H, Zakeri Z, Eskandari‐Nasab E. Association of PTPN22 rs2476601 and EGFR rs17337023 Gene polymorphisms and rheumatoid arthritis in Zahedan, Southeast Iran. Int J Immunogenet 2013;40(4):299-305.
  2. Schuerwegh A, Ioan-Facsinay A, Dorjee A, Roos J, Bajema I, Van Der Voort E, et al. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis. Proc Natl Acad Sci 2010;107(6):2586-91.
  3. Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol Int 2017;37(9):1551-7.
  4. Vellingiri B. AB0206 Expression of inflammatory genes and the il1b gene association with the severity of rheumatoid arthritis in tamil nadu population. BMJ Publishing Group Ltd; 2018.
  5. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73(7):1316-22.
  6. Venables P, Maini RN. Diagnosis and differential diagnosis of rheumatoid arthritis. UpToDate2012.
  7. Rossetti M, Spreafico R, Consolaro A, Leong JY, Chua C, Massa M, et al. TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis. Ann Rheum Dis 2017;76(2):435-41.
  8. Parle M, Kaura S. How to live with Rheumatoid Arthritis. Int Res J Pharm 2012;3(3):115-12.
  9. Gulati M, Farah Z, Mouyis M. Clinical features of rheumatoid arthritis. Medicine 2018;46(4):211-5.
  10. Martinec R, Pinjatela R, Balen D. Quality of Life in Patients with Rheumatoid Arthritis–a Preliminary Study. Acta Clin Croat 2019;58(1.):157-66.
  11. Kubota K, Yamashita H, Mimori A, editors. Clinical value of FDG-PET/CT for the evaluation of rheumatic diseases: rheumatoid arthritis, polymyalgia rheumatica, and relapsing polychondritis. Semin Nucl Med 2017 Jul;47(4):408-24.
  12. Santos EJ, Duarte C, Marques A, Cardoso D, Apóstolo J, da Silva JA, et al. Effectiveness of non-pharmacological and non-surgical interventions for rheumatoid arthritis: an umbrella review. JBI Evid Synth 2019;17(7):1494-531.
  13. Katz P. Fatigue in rheumatoid arthritis. Curr Rheumatol Rep 2017;19:1-10.
  14. Namas R, Joshi A, Ali Z, Al Saleh J, Abuzakouk M. Demographic and clinical patterns of rheumatoid arthritis in an Emirati cohort from United Arab Emirates. Int J Rheumatol 2019 Sep 25;2019:3057578.
  15. Zlatanović G, Veselinović D, Cekić S, Živković M, Đorđević-Jocić J, Zlatanović M. Ocular manifestation of rheumatoid arthritis-different forms and frequency. Bosn J Basic Med Sci 2010;10(4):323.
  16. Nannini C, Medina‐Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, et al. Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population‐based study. Arthritis Care Res 2013;65(8):1243-50.
  17. Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 2007;46(2):350-7.
  18. Kelly C. Lung disease in rheumatic disorders. Mediterr J Rheumatol 2019;30(3):147-54.
  19. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008;121(10):S21-S31.
  20. Hannawi S, Hannawi H, Alokaily F, Al Salmi I. Variables associated with subclinical atherosclerosis among rheumatoid arthritis patients of Gulf Cooperative Council countries. Saudi Med J 2020;41(2):128.
  21. Jeffery RC. Clinical features of rheumatoid arthritis. Medicine 2014;42(5):231-6.
  22. Ghosh SK, Bandyopadhyay D, Biswas SK, Darung I. Mucocutaneous manifestations in patients with rheumatoid arthritis: A cross-sectional study from Eastern India. Indian J Dermatol 2017;62(4):411.
  23. Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL. Development of reduced kidney function in rheumatoid arthritis. Am J Kid Dis 2014;63(2):206-13.
  24. Ku IA, Imboden JB, Hsue PY, Ganz P. Rheumatoid arthritis a model of systemic inflammation driving atherosclerosis. Circulation 2009;73(6):977-85.
  25. Mavrogeni S, Dimitroulas T, Sfikakis PP, Kitas GD, editors. Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance. Semin Arthritis Rheum 2013: Elsevier.
  26. Anyfanti P, Dara A, Angeloudi E, Bekiari E, Dimitroulas T, Kitas GD. Monitoring and managing cardiovascular risk in immune mediated inflammatory diseases. J Inflamm Res 2021;14:6893.
  27. Anaya J-M, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R. Autoimmunity: from bench to bedside [Internet]. 2013.
  28. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005;4(3):130-6.
  29. Spinel-Bejarano N, Quintana G, Heredia R, Yunis JJ, Caminos JE, Garcés MF, et al. Comparative study of elderly-onset rheumatoid arthritis and young-onset rheumatoid arthritis in a Colombian population: clinical, laboratory and HLA-DRB1 findings. Clin Exp Rheumatol 2013;31(1):40-6.
  30. Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006;8:1-15.
  31. Adams Waldorf KM, Nelson JL. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol Invest 2008;37(5-6):631-44.
  32. Mikuls TR, Saag K, Criswell L, Merlino L, Kaslow R, Shelton B, et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women’s Health Study. Ann Rheum Dis 2002;61(11):994-9.
  33. Chang J-M, Cheng C-M, Hung L-M, Chung Y-S, Wu R-Y. Potential use of Plectranthus amboinicus in the treatment of rheumatoid arthritis. Evid Based Complementary Altern Med 2010;7(1):115-20.
  34. Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 2018;6(1):15.
  35. Tobón GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmun Rev 2010;9(5):A288-A92.
  36. Traylor M, Curtis C, Patel H, Breen G, Hyuck Lee S, Xu X, et al. Genetic and environmental risk factors for rheumatoid arthritis in a UK African ancestry population: the GENRA case–control study. Rheumatology 2017;56(8):1282-92.
  37. Paul BJ, Kandy HI, Krishnan V. Pre-rheumatoid arthritis and its prevention. Eur J Rheumatol 2017;4(2):161.
  38. Padyukov L, Seielstad M, Ong R, Ding B, Ronnelid J, Seddighzadeh M, et al. Epidemiological Investigation of Rheumatoid Arthritis study g. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 2011;70(2):259-65.
  39. Edwards C, Cooper C. Early environmental factors and rheumatoid arthritis. Clin Exp Immunol 2006;143(1):1-5.
  40. Ruiz-Esquide V, Sanmartí R. Tobacco and other environmental risk factors in rheumatoid arthritis. Reumatología Clínica (English Edition) 2012;8(6):342-50.
  41. Gold L, Ward M, Dosemeci M, Roos AD. Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 2007;56(10):3189-201.
  42. Cooper GS, Parks CG, Schur PS, Fraser PA. Occupational and environmental associations with antinuclear antibodies in a general population sample. J Toxicol Environ Health Part A 2006;69(23):2063-9.
  43. Parks CG, Hoppin JA, De Roos AJ, Costenbader KH, Alavanja MC, Sandler DP. Rheumatoid arthritis in agricultural health study spouses: associations with pesticides and other farm exposures. Environ Health Perspect 2016;124(11):1728-34.
  44. Koureas M, Rachiotis G, Tsakalof A, Hadjichristodoulou C. Increased frequency of rheumatoid arthritis and allergic rhinitis among pesticide sprayers and associations with pesticide use. Int J Environ Res Public Health 2017;14(8):865.
  45. Meyer A, Sandler DP, Beane Freeman LE, Hofmann JN, Parks CG. Pesticide exposure and risk of rheumatoid arthritis among licensed male pesticide applicators in the agricultural health study. Environ Health Perspect 2017;125(7):077010.
  46. Angelotti F, Parma A, Cafaro G, Capecchi R, Alunno A, Puxeddu I. One year in review 2017: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 2017;35(3):368-78.
  47. Ishikawa Y, Terao C. The impact of cigarette smoking on risk of rheumatoid arthritis: a narrative review. Cells 2020;9(2):475.
  48. Kelley KW, Weigent DA, Kooijman R. Protein hormones and immunity. Brain Behav Immun 2007;21(4):384-92.
  49. Alam J, Jantan I, Bukhari SNA. Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy. Biomed Pharmacother 2017;92:615-33.
  50. McMurray RW. Estrogen, prolactin, and autoimmunity: actions and interactions. Int Immunopharmacol 2001;1(6):995-1008.
  51. Clapp C, Adán N, Ledesma-Colunga MG, Solis-Gutierrez M, Triebel J, Martinez de la Escalera G. The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview. Cell Mol Life Sci 2016;73:2929-48.
  52. Costanza M, Binart N, Steinman L, Pedotti R. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev 2015;14(3):223-30.
  53. Pelekanou V, Kampa M, Kiagiadaki F, Deli A, Theodoropoulos P, Agrogiannis G, et al. Estrogen anti‐inflammatory activity on human monocytes is mediated through cross‐talk between estrogen receptor ERα36 and GPR30/GPER1. J Leukoc Biol 2016;99(2):333-47.
  54. Capellino S, Straub RH, Cutolo M. Aromatase and regulation of the estrogen‐to‐androgen ratio in synovial tissue inflammation: common pathway in both sexes. Ann NY Acad Sci 2014;1317(1):24-31.
  55. Stubelius A, Andersson A, Islander U, Carlsten H. Ovarian hormones in innate inflammation. Immunobiol 2017;222(8-9):878-83.
  56. Orellana C, Saevarsdottir S, Klareskog L, Karlson EW, Alfredsson L, Bengtsson C. Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2017;76(11):1845-52.
  57. Chen H, Wang J, Zhou W, Yin H, Wang M. Breastfeeding and risk of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 2015;42(9):1563-9.
  58. Adab P, Jiang CQ, Rankin E, Tsang YW, Lam TH, Barlow J, et al. Breastfeeding practice, oral contraceptive use and risk of rheumatoid arthritis among Chinese women: the Guangzhou Biobank Cohort Study. Rheumatology 2014;53(5):860-6.
  59. Shen P, Jiao Y, Miao L, Chen Jh, Momtazi‐Borojeni AA. Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management. J Cell Mol Med 2020;24(21):12234-45.
  60. Yamamoto K, Okada Y, Suzuki A, Kochi Y. Genetic studies of rheumatoid arthritis. Proc Jpn Acad, Ser B 2015;91(8):410-22.
  61. Knoerzer DB, Donovan MG, Schwartz BD, Mengle-Gaw LJ. Clinical and histological assessment of collagen-induced arthritis progression in the diabetes-resistant BB/Wor rat. Toxicol Pathol 1997;25(1):13-9.
  62. Taneja V, Krco CJ, Behrens MD, Luthra HS, Griffiths MM, David CS. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol Immunol 2007;44(11):2988-96.
  63. El-Gabalawy H, Robinson D, Daha N, Oen K, Smolik I, Elias B, et al. Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population. Genes Immun 2011;12(7):568-74.
  64. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham III CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569-81.
  65. Tamhane A, Redden DT, McGwin G, Brown EE, Westfall AO, Reynolds RJ, et al. Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis. J Rheumatol 2013;40(11):1812-22.
  66. Singh HV, Pandey A, Shrivastava AK, Raizada A, Singh SK, Singh N. Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta 2013;419:136-8.
  67. Vinapamula KS, Pemmaraju SV, Bhattaram SK, Bitla AR, Manohar SM. Serum adenosine deaminase as inflammatory marker in rheumatoid arthritis. Journal of clinical and diagnostic research: JCDR 2015;9(9):BC08.
  68. Ally MM. Biomarkers in rheumatoid arthritis-the old and new. SA Orthop J 2013;12(4):19-22.
  69. Sudoł-Szopińska I, Ćwikła JB. Current imaging techniques in rheumatology: MRI, scintigraphy and PET. Pol J Radiol 2013;78(3).
  70. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. NEJM 2011;365(23):2205-19.
  71. Raza K, Falciani F, Curnow SJ, Ross EJ, Lee C-Y, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:1-12.
  72. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis?: II. T cell‐independent mechanisms from beginning to end. Arthritis Rheum 2002;46(2):298-308.
  73. Zhang J-M, An J. Cytokines, inflammation and pain. International anesthesiology clinics. 2007;45(2):27.
  74. Marston B, Palanichamy A, Anolik JH. B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol 2010;22(3):307.
  75. Feldman M, Ginsburg I. A Novel Hypothetical Approach to Explain the Mechanisms of Pathogenicity of Rheumatic Arthritis. Mediterr J Rheumatol 2021;32(2):112.
  76. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35(1):35-42.
  77. Szodoray P, Alex P, Chappell-Woodward C, Madland T, Knowlton N, Dozmorov I, et al. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology 2007;46(3):417-25.
  78. Saklatvala J, Nagase H, Salvesen G, Poole AR, Nelson F, Dahlberg L, et al., editors. Proteolysis of the collagen fibril in osteoarthritis. Biochemical Society Symposia; 2003: Portland Press.
  79. Choy E, Isenberg D, Garrood T, Farrow S, Ioannou Y, Bird H, et al. Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double‐blind, placebo‐controlled, dose‐escalation trial. Arthritis Rheum 2002;46(12):3143-50.
  80. Schotte H, Schlüter B, Drynda S, Willeke P, Tidow N, Assmann G, et al. Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64(4):575-81.
  81. Jahid M, Jha PK, Chawla D, Avasthi R, Ahmed RS. Tumor necrosis factor-α-308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-α. Clin Rheumatol 2017;36:2209-16.
  82. Jahid M, Chawla D, Avasthi R, Ahmed RS. Association of polymorphic variants in IL1B gene with secretion of IL-1β protein and inflammatory markers in north Indian rheumatoid arthritis patients. Gene 2018;641:63-7.
  83. Jahid M, Avasthi R, Ahmed RS. Interleukin10-1082 A/G polymorphism: Allele frequency, correlation with disease markers, messenger RNA and serum levels in North Indian rheumatoid arthritis patients. Clin Biochem 2018;55:80-5.
  84. Quiñonez-Flores CM, González-Chávez SA, Del Rio Najera D, Pacheco-Tena C. Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: a systematic review. BioMed Res Int 2016;2016.
  85. Mateen S, Moin S, Khan AQ, Zafar A, Fatima N. Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis. PLoS One 2016;11(4):e0152925.
  86. Das DC, Jahan I, Uddin MG, Hossain MM, Chowdhury MAZ, Fardous Z, et al. Serum CRP, MDA, vitamin C, and trace elements in Bangladeshi patients with rheumatoid arthritis. Biol Trace Elem Res 2021;199(1):76-84.
  87. Metsios GS, Fenton SA, Moe HR, van der Esch M, van Zanten JV, Koutedakis Y, et al. Implementation of Physical Activity into routine Clinical pracTice in Rheumatic Musculoskeletal Disease: The IMPACT-RMD study protocol and rationale. Mediterr J Rheumatol 2019;30(4):231.
  88. Christie A, Jamtvedt G, Dahm KT, Moe RH, Haavardsholm EA, Hagen KB. Effectiveness of nonpharmacological and nonsurgical interventions for patients with rheumatoid arthritis: an overview of systematic reviews. Phys Ther 2007;87(12):1697-715.
  89. Metsios GS, Brodin N, Vlieland TPV, Van den Ende CH, Stavropoulos-Kalinoglou A, Fatouros I, et al. Position statement on exercise dosage in rheumatic and musculoskeletal diseases: the role of the IMPACT-RMD Toolkit. Mediterr J Rheumatol 2021;32(4):378.
  90. Sobejana M, van den Hoek J, Metsios G, Kitas G, van der Leeden M, Verberne S, et al. Exercise intervention on cardiorespiratory fitness in rheumatoid arthritis patients with high cardiovascular disease risk: a single-arm pilot study. Clin Rheumatol 2022:1-10.
  91. Metsios GS, Moe R, Van Der Esch M, Van Zanten JV, Fenton S, Koutedakis Y, et al. The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis. Rheumatol Int 2020;40(3):347-57.
  92. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular manifestations in rheumatoid arthritis. Maedica 2010;5(4):286.
  93. Verschueren P, Esselens G, Westhovens R. Predictors of remission, normalized physical function, and changes in the working situation during follow‐up of patients with early rheumatoid arthritis: an observational study. Scand J Rheumatol 2009;38(3):166-72.
  94. Kumar P, Banik S. Pharmacotherapy options in rheumatoid arthritis. Clin Med Insights: Arthritis Musculoskelet Dis 2013;6:CMAMD. S5558.
  95. Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen J. Methotrexate as the" anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 2003;21(5; SUPP 31):S179-S85.
  96. Kleinert S, Tony H-P, Krause A, Feuchtenberger M, Wassenberg S, Richter C, et al. Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study. Rheumatol Int 2012;32:2759-67.
  97. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Care Res 2008;59(6):762-84.
  98. Chakraborty A, Tannenbaum S, Rordorf C, Lowe PJ, Floch D, Gram H, et al. Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody. Clin Pharmacokinet 2012;51:e1-e18.
  99. Marketos N, Bournazos I, Ioakimidis D. Canakinumab for refractory RA: a case report. Mediterr J Rheumatol 2018;29(3):170-2.
  100. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64(5):625-39.
  101. Tiippana-Kinnunen T, Paimela L, Peltomaa R, Kautiainen H, Laasonen L, Leirisalo-Repo M. Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-up. Clin Exp Rheumatol 2014;32(1):88-94.
  102. Prior Y, Amanna AE, Bodell SJ, Hammond A. A qualitative evaluation of occupational therapy-led work rehabilitation for people with inflammatory arthritis: Patients’ views. Br J Occup Ther 2017;80(1):39-48.